Omiya, Japan

Taketsugu Seki

This inventor holds 3 USPTO granted patents. Top assignee: Nikken Chemicals Co., Ltd.. Active years: 1990-2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Taketsugu Seki. Retrieved from https://idiyas.com/inventor/taketsugu-seki

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.1

ph-index = 2

Forward Citations = 49(Granted Patents)


Location History:

  • Saitama, JP (1990)
  • Omiya, JP (1998 - 2002)

Company Filing History:


Years Active: 1990-2002

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Taketsugu Seki

Introduction

Taketsugu Seki is a prominent inventor based in Omiya, Japan. He has made significant contributions to the field of medicinal chemistry, holding a total of three patents. His work focuses on developing innovative compounds that have potential applications in pharmaceuticals.

Latest Patents

Among his latest patents are the Triazolo-1,4-diazepine compounds and medicinal compositions containing the same. Additionally, he has developed a 1,4-dihydropyridine compound and a pharmaceutical composition containing it. These inventions showcase his commitment to advancing medical science through innovative chemical solutions.

Career Highlights

Taketsugu Seki is associated with Nikken Chemicals Co., Ltd., where he applies his expertise in chemistry to drive research and development. His work has been instrumental in creating new medicinal compounds that can lead to improved therapeutic options.

Collaborations

He has collaborated with notable coworkers, including Shigeyuki Tasaka and Tetsuro Sano. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries.

Conclusion

Taketsugu Seki's contributions to medicinal chemistry through his patents and collaborations highlight his role as a key innovator in the field. His work continues to pave the way for advancements in pharmaceutical applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…